Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
What value do cell cycle inhibitors have in the treatment of myelodysplastic syndrome?
Journal: Expert opinion on pharmacotherapy
Published: April 18, 2023
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements.
Journal: American journal of hematology
Published: September 14, 2022
Keeping up with venetoclax for leukemic malignancies: key findings, optimal regimens, and clinical considerations.
Journal: Expert review of clinical pharmacology
Published: November 18, 2021
Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax.
Journal: Leukemia research reports
Published: April 10, 2021
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS).
Journal: American journal of hematology
Published: February 02, 2021
Showing 1-5 of 5
Last Updated: 09/26/2026